scholarly article | Q13442814 |
P356 | DOI | 10.1097/JTO.0B013E3182307F62 |
P698 | PubMed publication ID | 22011669 |
P2093 | author name string | Hae Won Lee | |
Young-Joon Kim | |||
Sung Han Kim | |||
Yong-Jae Kwon | |||
Jong Ho Park | |||
Moon Chul Kang | |||
Jae Soo Koh | |||
Seog Joo Lee | |||
Jae Bum Bae | |||
P433 | issue | 1 | |
P921 | main subject | lung cancer | Q47912 |
DNA methylation | Q874745 | ||
P304 | page(s) | 20-33 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
P1476 | title | Genome-wide analysis of DNA methylation and the gene expression change in lung cancer | |
P478 | volume | 7 |
Q37144743 | A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations |
Q36772595 | A solid-state control system for dynein-based ciliary/flagellar motility |
Q57796271 | Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma |
Q36753304 | Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer |
Q38730064 | Aspirin and colorectal cancer: the promise of precision chemoprevention. |
Q35246178 | Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants |
Q40223929 | Biochemical and biophysical characterization of cytokine-like protein 1 (CYTL1). |
Q91868379 | CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation |
Q92192957 | Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery |
Q64963036 | Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. |
Q31101539 | Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers |
Q39847007 | Cytokine-like 1 Chemoattracts Monocytes/Macrophages via CCR2. |
Q52370391 | Developing DNA methylation-based diagnostic biomarkers. |
Q39086320 | Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes |
Q36706060 | Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer |
Q37355527 | ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer |
Q41606049 | Effect of vitrification on promoter methylation and the expression of pluripotency and differentiation genes in mouse blastocysts |
Q36893810 | Enhancer methylation dynamics contribute to cancer plasticity and patient mortality |
Q35880987 | Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer |
Q44986560 | Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma |
Q36885903 | Epigenetic therapy in lung cancer |
Q35154365 | Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer |
Q26996766 | Epigenetics of lung cancer |
Q36918646 | Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B-cell lymphoma cells and their association with clinical features |
Q33604172 | Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer |
Q35078001 | Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing |
Q42019243 | Genome-wide DNA methylation profiling of non-small cell lung carcinomas |
Q37642592 | Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma. |
Q30668767 | Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. |
Q36676636 | LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations |
Q38023237 | Maspin: molecular mechanisms and therapeutic implications |
Q35160337 | Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients |
Q35781470 | MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells |
Q38321676 | Novel target genes and a valid biomarker panel identified for cholangiocarcinoma |
Q36182156 | Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome |
Q92026618 | Protein Cytl1: its role in chondrogenesis, cartilage homeostasis, and disease |
Q47343643 | Proteomics analysis of human breast milk to assess breast cancer risk. |
Q33558221 | QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments |
Q35076075 | Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma |
Q30538934 | The MIA complex is a conserved and novel dynein regulator essential for normal ciliary motility |
Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
Q37645061 | Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system |
Q90129075 | [Application of GLAD-PCR Assay for Study on DNA Methylation in Regulatory Regions of Some Tumor-Suppressor Genes in Lung Cancer] |
Q41737859 | miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis |
Search more.